BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 12083004)

  • 1. Natural substrates of the proteasome and their recognition by the ubiquitin system.
    Ulrich HD
    Curr Top Microbiol Immunol; 2002; 268():137-74. PubMed ID: 12083004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2EPF and RAD6 are recognized by 26 S proteasome subunit 5.
    Baboshina OV; Haas AL
    J Biol Chem; 1996 Feb; 271(5):2823-31. PubMed ID: 8576261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation.
    Swanson R; Locher M; Hochstrasser M
    Genes Dev; 2001 Oct; 15(20):2660-74. PubMed ID: 11641273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-independent proteolytic functions of the proteasome.
    Orlowski M; Wilk S
    Arch Biochem Biophys; 2003 Jul; 415(1):1-5. PubMed ID: 12801506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications.
    Ciechanover A; Orian A; Schwartz AL
    J Cell Biochem Suppl; 2000; 34():40-51. PubMed ID: 10762014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins.
    Crews CM
    Curr Opin Chem Biol; 2003 Oct; 7(5):534-9. PubMed ID: 14580555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of polypeptides corresponding to the amino terminus of the F-box proteins Cdc4p and Met30p inhibits ubiquitin ligase activities of their SCF complexes.
    Dixon C; Brunson LE; Roy MM; Smothers D; Sehorn MG; Mathias N
    Eukaryot Cell; 2003 Feb; 2(1):123-33. PubMed ID: 12582129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UFD4 lacking the proteasome-binding region catalyses ubiquitination but is impaired in proteolysis.
    Xie Y; Varshavsky A
    Nat Cell Biol; 2002 Dec; 4(12):1003-7. PubMed ID: 12447385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.
    Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W
    EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-dependent proteolysis and cell cycle control in yeast.
    Chun KT; Mathias N; Goebl MG
    Prog Cell Cycle Res; 1996; 2():115-27. PubMed ID: 9552389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc20 protein contains a destruction-box but, unlike Clb2, its proteolysisis not acutely dependent on the activity of anaphase-promoting complex.
    Goh PY; Lim HH; Surana U
    Eur J Biochem; 2000 Jan; 267(2):434-49. PubMed ID: 10632713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets.
    Kaiser P; Moncollin V; Clarke DJ; Watson MH; Bertolaet BL; Reed SI; Bailly E
    Genes Dev; 1999 May; 13(9):1190-202. PubMed ID: 10323869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
    Burger AM; Seth AK
    Eur J Cancer; 2004 Oct; 40(15):2217-29. PubMed ID: 15454246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain.
    Verma R; Peters NR; D'Onofrio M; Tochtrop GP; Sakamoto KM; Varadan R; Zhang M; Coffino P; Fushman D; Deshaies RJ; King RW
    Science; 2004 Oct; 306(5693):117-20. PubMed ID: 15459393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
    Guharoy M; Bhowmick P; Tompa P
    J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'ER degradation' of a mutant yeast plasma membrane protein by the ubiquitin-proteasome pathway.
    Galan JM; Cantegrit B; Garnier C; Namy O; Haguenauer-Tsapis R
    FASEB J; 1998 Mar; 12(3):315-23. PubMed ID: 9506475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferring substrates to the 26S proteasome.
    Hartmann-Petersen R; Seeger M; Gordon C
    Trends Biochem Sci; 2003 Jan; 28(1):26-31. PubMed ID: 12517449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.
    Van Sant C; Hagglund R; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8815-20. PubMed ID: 11447293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating enzymes: their functions and substrate specificity.
    Soboleva TA; Baker RT
    Curr Protein Pept Sci; 2004 Jun; 5(3):191-200. PubMed ID: 15180524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.